TEITUR TROPHICS
Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
TEITUR TROPHICS
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2020-01-01
Address:
Aarhus, Midtjylland, Denmark
Country:
Denmark
Website Url:
http://www.teiturtrophics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28 M EUR
Technology used in webpage:
German Server Location
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Carcinotech
Carcinotech is focused on treating cancers and is based at the Roslin Innovation Centre on the outskirts of Edinburgh.
CHARM Therapeutics
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Design Therapeutics
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Kurve Therapeutics
Kurve Therapeutics engages in the development of treatments for neurodegenerative diseases.
Stalicla
STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
VectivBio
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Volastra Therapeutics
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - Teitur Trophics
p53
p53 investment in Series A - Teitur Trophics
Sound Bioventures
Sound Bioventures investment in Series A - Teitur Trophics
Innovestor
Innovestor investment in Series A - Teitur Trophics
Industrifonden
Industrifonden investment in Series A - Teitur Trophics
Official Site Inspections
http://www.teiturtrophics.com Semrush global rank: 15.64 M Semrush visits lastest month: 1
- Host name: dedi4227.your-server.de
- IP address: 78.46.143.48
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Teitur Trophics"
About Us - Teiturtrophics
About Us. Teitur is Old Norse for happiness. Our ambition and commitment is to create new treatments for patients suffering from neurodegenerative diseases to help them live a longer, better and happier life.See details»
Teitur Trophics - Crunchbase Company Profile & Funding
Contact Email [email protected] Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company …See details»
Board of Directors – Teiturtrophics
Casper Breum Sound Bioventures. Before founding Sound Bioventures, Casper was a Senior Partner at Lundbeckfonden Ventures, where he worked for 12 years, and led investments and …See details»
Teitur Trophics Company Profile 2024: Valuation, Funding
Teitur Trophics General Information Description. Operator of medical research company intended to study small peptides involved in neurogenerative diseases. The company's research studies …See details»
Teitur Trophics - LinkedIn
Teitur Trophics | 1,647 followers on LinkedIn. Teitur Trophics is a danish biotech company, developing novel treatments for neurodegenerative diseases. | Teitur develops novel therapeutics for ...See details»
Teitur Trophics Raises EUR 28M in Series A Financing to Advance …
Mar 14, 2023 /PRNewswire/ -- Teitur Trophics ("Teitur"), a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative diseases,...See details»
Teitur Trophics ApS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Teitur Trophics ApS with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Endocrinology and Metabolic ...See details»
Teitur Trophics - VentureRadar
Similar Companies: Origami Therapeutics USA Privately Held Origami Therapeutics is a preclinical-stage biopharmaceutical company that focuses on developing novel protein …See details»
Teitur Trophics ApS - life-sciences-europe.com
Upcoming Events. Bits & Pretzels 2024 Founders Festival München (Munich) Fierce Biotech Summit 2024 Boston; Chardan Genetic Medicines Conference 2024 New YorkSee details»
Our Team - Teiturtrophics
Edward Browne Chief Development Officer. Ed has over 20 years experience in drug discovery and development, spanning big Pharma, CRO, biotech and consultancy roles supporting the successful progression of a number of …See details»
Danish biotech firm Teitur Trophics bags €28M to advance …
Aarhus, Denmark-based Teitur Trophics, a biotech company, announced on Tuesday, March 14, that it has secured €28M in a Series A round of funding co-led by Sunstone Life Science …See details»
Kromann Reumert assists Teitur Trophics in connection with their …
Mar 27, 2023 Read more: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases – Teiturtrophics …See details»
Series A financing at Teitur Trophics to fund ... - BioWorld
Mar 14, 2023 Teitur Trophics ApS, a spinout from Aarhus University seeded by the Bioinnovation Institute in 2020, has completed a €28 million (US$30.1 million) series A …See details»
Teitur Trophics - Sunstone
Teitur Trophics. Teitur develops novel therapeutics for treating or preventing neurodegenerative diseases.. Teitur is Old Norse for happiness. Teitur’s ambition and commitment is to create …See details»
Teitur Trophics – Industrifonden
Teitur Trophics is a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative diseases. The company has developed a platform of first-in …See details»
Teitur Trophics Raises EUR 28M in Series A Financing to Advance …
Aarhus, Denmark March 14 th, 2023: Teitur Trophics (“Teitur”), a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative diseases, today …See details»
Frontotemporal Dementia – Teiturtrophics
Overview. Frontotemporal dementia (FTD) or frontotemporal degenerations refer to a group of disorders caused by progressive nerve cell loss in the brain’s frontal lobes (the areas behind …See details»
News - Teiturtrophics
Oct 31, 2023 Our CEO Simon Mølgaard was interviewed by Sejelas where he talks about Teitur Trophics and our commitment to developing novel treatments for treating patients suffering …See details»
Our Science - Teiturtrophics
Frontotemporal Dementia. Frontotemporal dementia (FTD) refers to a group of disorders caused by progressive nerve cell loss in the brain’s frontal lobes or its temporal lobes.The nerve cell …See details»